MED-EL Overview
Pro stress-test →MED-EL is a global medical technology company specializing in hearing implants and devices. Run by co-founder and CEO Ingeborg Hochmair, a scientist and researcher in the field of hearing implants, the company enables people in 140 countries to enjoy the gift of hearing with MED-EL devices.
Strategic Profile
Pro stress-test →MED-EL's hearing solutions include cochlear and middle ear implant systems, Electric Acoustic Stimulation hearing implant systems, auditory brainstem implants, and surgical and non-surgical bone conduction devices. MED-EL ranks 3rd amongst 16 active competitors, establishing it as a top-tier player in the implantable hearing devices market with a differentiated product portfolio targeting diverse hearing loss profiles.
Competitive Landscape
Pro stress-test →Top competitors include Cochlear, Advanced Bionics, and Oticon Medical. MED-EL maintains competitive advantage through its comprehensive product portfolio addressing multiple hearing loss types and its strong R&D network, positioning it as a diversified alternative to competitors often focused on specific implant modalities.
Industry Context
MED-EL operates in Hearing Implant Devices / Implantable Medical Devices.
Key facts
Founded: 1990 · Headquarters: Innsbruck, Austria · Employees: 2,118 · Revenue: $715.5M